Glaucoma Studies
Glaucoma/Ocular Hypertension
Not Applicable (Service Provider)Active
Key Facts
Indication
Glaucoma/Ocular Hypertension
Phase
Not Applicable (Service Provider)
Status
Active
Company
About Oculus Research
Oculus Research is a private, US-based clinical research organization founded in 2014, operating as a site management organization (SMO) that conducts trials for external sponsors. The company has a strong track record in ophthalmology, having contributed to the development and FDA approval of nine treatments, including TYRVAYA, VEVYE, and MIEBO. Its business model is service-based, generating revenue from sponsors and CROs for patient recruitment and trial execution across a diverse range of therapeutic areas beyond eye care, such as vaccines, diabetes, and mental health.
View full company profileTherapeutic Areas
Other Glaucoma/Ocular Hypertension Drugs
| Drug | Company | Phase |
|---|---|---|
| Aibeta® BAC-free formulation | Senju Pharmaceutical | Approved |
| Bimatoprost Sustained-Release | Galderma Group | Phase 3 |